Currently, a number of studies have demonstrated that FASN is highly expressed in a wide range of tumor cells, through the de novo synthesis of fatty acids to satisfy the high-energy requirements of tumor cells and promote malignant tumor progression, including tumor proliferation, invasion, angiogenesis, and metastasis to other lesions [2,3,4,5]. The gene discussed is FASN; the disease is cancer.